Kovitz Investment Group Partners LLC Sells 53,987 Shares of Corteva, Inc. $CTVA

Kovitz Investment Group Partners LLC trimmed its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 62.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,604 shares of the company’s stock after selling 53,987 shares during the quarter. Kovitz Investment Group Partners LLC’s holdings in Corteva were worth $2,185,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CTVA. Drummond Knight Asset Management Pty Ltd purchased a new position in shares of Corteva during the fourth quarter valued at approximately $25,713,000. Alberta Investment Management Corp purchased a new stake in Corteva in the third quarter worth $5,018,000. Avior Wealth Management LLC boosted its holdings in Corteva by 464.7% in the fourth quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after acquiring an additional 27,075 shares in the last quarter. HighTower Advisors LLC boosted its holdings in Corteva by 8.6% in the third quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock valued at $12,352,000 after acquiring an additional 14,436 shares in the last quarter. Finally, Arbejdsmarkedets Tillaegspension purchased a new position in Corteva during the 4th quarter valued at $23,679,000. 81.54% of the stock is currently owned by institutional investors.

Get Corteva alerts:

Corteva Trading Down 0.0%

Corteva stock opened at $78.57 on Friday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The company has a market capitalization of $52.55 billion, a price-to-earnings ratio of 46.22, a price-to-earnings-growth ratio of 2.40 and a beta of 0.57. The business’s fifty day simple moving average is $79.64 and its two-hundred day simple moving average is $75.69. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s revenue was up 11.0% on a year-over-year basis. During the same period last year, the company earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were issued a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s payout ratio is 42.35%.

Analyst Upgrades and Downgrades

Several research analysts have commented on CTVA shares. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Barclays boosted their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Oppenheimer increased their price target on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Rothschild & Co Redburn raised their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, BNP Paribas Exane upped their target price on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $88.81.

View Our Latest Stock Analysis on Corteva

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles

• Five stocks we like better than Corteva
• Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
• Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
• Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
• Why Kroger’s Pullback Could Be a Gift for Patient Investors

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.